Insights

Global Footprint MGI operates globally with R&D, manufacturing, training, and after-sales facilities across six continents. This global reach enables rapid deployment and local support, presenting opportunities for regional service tiers, localized logistics, and multi-year maintenance contracts for instruments and reagents.

End-to-End Portfolio MGI offers a comprehensive suite across SEQ ALL, GLI, and Multi-Omics, enabling integrated sequencing and analytics. This creates cross-sell opportunities for bundled instrument sales with consumables, reagents, and analytics software, plus workflow automation and AI-enabled lab intelligence offerings.

Data and Analytics The company’s digital focus aligns with data-centric sales prospects in data management, cloud storage, and multi-omics analytics. Propose data pipelines, scalable storage and HPC capabilities, data governance, and deployment of ML models to accelerate research and precision medicine initiatives.

Ops Enablement With SAP, Power BI, and Salesforce Marketing Cloud in its tech stack, there is appetite for enterprise automation and CRM-driven expansion. Opportunities include ERP optimization, procurement and maintenance workflow integration, and enhanced field service orchestration and predictive maintenance.

Training Partnerships MGI emphasizes training and after-sales service, making it a fit for global training programs and regional partner networks. Offer scalable e-learning, remote support capabilities, and co-branded service programs to accelerate instrument adoption and customer success.

MGI Tech Stack

MGI uses 8 technology products and services including Rippling, ISO 13485, Salesforce, and more. Explore MGI's tech stack below.

  • Rippling
    Applicant Tracking Systems
  • ISO 13485
    Certificates
  • Salesforce
    Customer Relationship Management
  • NetSuite
    E-commerce
  • Element UI
    Javascript Frameworks
  • Wow
    Marketing Analytics
  • Microsoft Office
    Office Suites
  • Google Analytics
    Web Analytics

Media & News

MGI's Email Address Formats

MGI uses at least 2 format(s):
MGI Email FormatsExamplePercentage
First.Last@mgitech.cnJohn.Doe@mgitech.cn
100%
FirstLast@mgi-tech.comJohnDoe@mgi-tech.com
79%
FLast@mgi-tech.comJDoe@mgi-tech.com
10%
First.Last@mgi-tech.comJohn.Doe@mgi-tech.com
6%
LastFirst@mgi-tech.comDoeJohn@mgi-tech.com
5%

Frequently Asked Questions

What is MGI's stock symbol?

Minus sign iconPlus sign icon
MGI is a publicly traded company; the company's stock symbol is MTG.

What is MGI's official website and social media links?

Minus sign iconPlus sign icon
MGI's official website is mgi-tech.com and has social profiles on LinkedIn.

What is MGI's SIC code NAICS code?

Minus sign iconPlus sign icon
MGI's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MGI have currently?

Minus sign iconPlus sign icon
As of July 2026, MGI has approximately 1.4K employees across 6 continents, including AsiaEuropeNorth America. Key team members include Vp Of Sales Europe & Africa: C. Z.Head Of South Europe: H. S. B.Head Of Sales Admin: H. M.. Explore MGI's employee directory with LeadIQ.

What industry does MGI belong to?

Minus sign iconPlus sign icon
MGI operates in the Biotechnology Research industry.

What technology does MGI use?

Minus sign iconPlus sign icon
MGI's tech stack includes RipplingISO 13485SalesforceNetSuiteElement UIWowMicrosoft OfficeGoogle Analytics.

What is MGI's email format?

Minus sign iconPlus sign icon
MGI's email format typically follows the pattern of First.Last@mgitech.cn. Find more MGI email formats with LeadIQ.

How much funding has MGI raised to date?

Minus sign iconPlus sign icon
As of July 2026, MGI has raised $1.2B in funding. The last funding round occurred on May 28, 2020.

When was MGI founded?

Minus sign iconPlus sign icon
MGI was founded in 2016.
MGI logo

MGI

Biotechnology ResearchGuangdong, China1001-5000 Employees

MGI Tech Co., Ltd. operates in biotechnology research, focusing on the research and development, manufacture, and sale of life-science instruments, reagents, and related products. The company provides real-time data collection, multi-omics capabilities, and digital systems to support precision medicine, agriculture, healthcare, and other industries. Founded in 2016 and based in Shenzhen, Guangdong, China, MGI has established global research, manufacturing, training, and after-sales service facilities and serves customers across six continents. It is capable of independently developing and mass-producing clinical-grade gene sequencing instruments, enabling scalable sequencing from Gb to Tb levels. MGI maintains a full-stack portfolio across core life-science workflows, integrating sequencing capabilities with data processing and analytics to support diverse applications.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
MTG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
1001-5000

Section iconFunding & Financials

  • $1.2B

    MGI has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on May 28, 2020as a series_b.

  • $500M$1B

    MGI's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $1.2B

    MGI has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on May 28, 2020as a series_b.

  • $500M$1B

    MGI's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.